REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease
Por um escritor misterioso
Descrição
Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.
JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease
What is agitation that may happen with dementia due to Alzheimer's disease?
FDA OKs First Drug for Agitation in Alzheimer's Dementia
FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer's disease
Agitation in Alzheimer's: Rexulti® Makes Meaningful Improvements
Decision on Brexpiprazole for Alzheimer's Agitation Due in May
Otsuka, Lundbeck get Adcom for Rexulti in Alzheimer agitation
Otsuka, Lundbeck's sNDA for Rexulti received US FDA approval
Lundbeck, Otsuka dial down the drama for Rexulti agitation ad
Frontiers Understanding neuropsychiatric symptoms in Alzheimer's disease: challenges and advances in diagnosis and treatment
A silent struggle: Caregiving for a patient with agitation associated with dementia due to Alzheimer's disease - STAT
Psych News Alert: FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease
Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease
Lundbeck, Otsuka's Rexulti wins FDA nod for Alzheimer's agitation
Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
